PMPRB – Recommendations on Proposed Amendments to the Patented Medicines Regulations

In May 2017, Health Canada announced proposed amendments to the Patented Medicines Regulations. The amendments would enable the Patented Medicines Prices Review Board to better protect Canadians from paying excessive prices for patented drugs.

The regulations have not been changed in over 20 years, despite major changes in the pharmaceutical market. Canadians are now paying some of the highest drug prices in the developed world. This impacts patients and the sustainability of Canada’s health care system.

After this announcement, Health Canada opened a consultation period for feedback from May 16, 2017 to June 28, 2017.

Click here to view a joint submission prepared by seventeen organizations and submitted on June 28, 2017.

The seventeen organizations endorsing this submission include: Canadian Cancer Survivor Network, Canadian Psoriasis Network, Canadian Spondylitis Association, CNETS Canada, Hep C BC, Lung Cancer Canada, Lymphoma Canada, Melanoma Network of Canada, Myeloma Canada, Ontario Caregivers Coalition, Rethink Breast Cancer, Save Your Skin Foundation,  Schizophrenia Society of Ontario, Sickle Cell Awareness Group of Ontario, Sickle Cell Disease Association of Canada, The Lung Association – Ontario, and CONECTed.